Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agrigenetics was a foundational agricultural biotechnology company that specialized in the genetic modification of crops to improve yield and resistance to environmental stressors. Founded in 1979, the company was a leader in the first wave of biotech firms, utilizing recombinant DNA technology to develop traits such as insect resistance and herbicide tolerance in major row crops. Its research and development efforts significantly contributed to the commercialization of genetically modified seeds, including Bt corn and high-quality sunflower varieties. Following its acquisition by Lubrizol and subsequent integration into Dow AgroSciences, Agrigenetics' intellectual property and germplasm became core components of the modern Corteva Agriscience portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agrigenetics.